Investors

Financial press releases

Financial press releases

25 February 2021, Sophia Antipolis, France

Median strengthens its iBiopsy® leadership team with the appointment of Thomas Bonnefont as Chief Operating and Commercial Officer and the appointment of Mike Doherty as Sr. Strategy Advisor, Product Development

These two appointments follow a series of first successful achievements for iBiopsy® in 2020 and early 2021. Median prepares to launch its iBiopsy® product development plan, including regulatory aspects, define its go-to-market strategy then expand its iBiopsy® operations globally.

Read more
16 February 2021, Sophia Antipolis, France

iBiopsy®: Median Technologies continues its strong positioning in early-stage diagnosis with a new iBiopsy® Clinical Development Plan on Lung Cancer Screening (LCS)

Median is building a cloud based end-to-end approach performing both localization and discrimination of malignant and benign lung lesions. The company plans to demonstrate the potential of deep learning models to increase the accuracy, consistency and adoption of lung cancer screening worldwide. First results for a proof of concept on a cohort of 1,800 patients are expected in H2, 2021.

Read more

Filter financial press releases by year